Saskatchewan

Image: 
Tue
19
Jan

Alcanna to spin off retail arm to YSS with focus on cheaper pot

Alcanna Inc. said Monday it is spinning off its cannabis retailer division and merging it with YSS Corp. in an all-stock deal that would value the combined company at about $130 million. 

The new company is expected to be renamed Nova Cannabis Inc. and will rebrand most of its retail footprint to Value Buds, a move that acknowledges the growing demand for cheaper cannabis in the Canadian recreational market. 

"This new offering, new Nova Cannabis, is really laser-focused on a segment of the marketplace that's proven to exist -- and that's the value-conscious consumer," said Darren Karasiuk, who will be the chief executive officer of the combined company and is a former chief commercial officer for Aurora Cannabis  Inc., in a broadcast interview. 

Fri
18
Dec

A third of Canadians with cancer saying yes to cannabis: Alberta study

doctor consulting with patient

About of third of cancer patients taking part in a University of Alberta-affiliated study report using medical cannabis, a percentage that climbed about seven points between 2007 and 2016.

“Within this study cohort of Canadian adults with current cancer diagnosis, cannabis use is not uncommon,” conclude authors of the study published this month in Expert Reviews in Pharmacoeconomics & Outcome Research.

Tue
10
Nov

USask researchers to study how cannabis use during pregnancy affects fetus' brain development

University of Saskatchewan (USask) pharmacologist Robert Laprairie will use a Brain Canada research grant to determine how a mother's use of cannabis during pregnancy affects the brain of the developing fetus she's carrying.

Laprairie is one of 20 Canadian neuroscientists each awarded $100,000 today as part of Brain Canada's Future Leaders in Canadian Brain Research Program.

Following on Canada's legalization of cannabis in 2018, there is merited concern that people might seek out cannabis either for medicinal or recreational use during pregnancy."

Robert Laprairie, USask Pharmacologist

Mon
10
Aug
Thu
16
Jul

Saskatoon company isolates coronavirus antigen in plant cells

A Saskatoon life sciences company known for its work with medical cannabis says it has successfully isolated the antigen for SARS-CoV-2 in plant cells.

Zyus Life Sciences Inc. CEO Brent Zettl says it’s an important first step that shows plants can effectively “photocopy” proteins that could be ingredients in a COVID-19 vaccine.

Thu
02
Jul

We ranked Canada's cannabis-friendly provinces from worst to best

Canadians are clearly in love with cannabis, but not all provinces were created equal when it comes to permitting pot. While the historic Cannabis Act applies to all provinces, the rules around distribution and consumption fall to the provinces — and municipalities have some say on it, too.

That’s why for Canada Day, The GrowthOp takes a look at the growing industry from coast-to-coast — crunching the data on price, consumption habits, number of stores, public consumption options and the ability to grow at home — to find out which provinces are rolling out the red carpet for weed and which are still warming up to the country’s second favourite leaf.

Here are our findings.

Thu
25
Jun

Pure Sunfarms starts shipping to Saskatchewan and Manitoba

Pure Sunfarms, the joint venture between veteran vegetable grower Village Farms International Inc. (TSX and NASDAQ: VFF) and medical cannabis company Emerald Health Therapeutics Inc. (TSX-V: EMH), began shipping its products to Saskatchewan Wednesday.

Thu
18
Jun

City of Saskatoon committee recommends significant reduction in cannabis retailer license fees

The City of Saskatoon’s Planning, Development and Community Services Committee has unanimously recommended that cannabis retailer license fees be reduced from the current $20,000 to $4,500 when the SLGA begins accepting new applications for stores in September.

Subsequent business license renewals are expected to remain at $85 annually. To date, $120,000 in revenue from business licensing fees has been received.

Tue
12
May

Saskatoon medical cannabis firm working with researchers on potentially 'plant-based' COVID-19 vaccine

A local firm specializing in medical cannabis science is lending its expertise to the University of Saskatchewan-based VIDO-InterVac research lab's quest for a COVID-19 vaccine.

The lab, which received 23 million dollars in federal funding in March to aid its COVID-19-related research, recently moved into animal trials as part of its research.

Mon
04
May

Canopy Growth sees up to $800M charge on global restructuring

Canopy Growth Corp. announced sweeping changes Thursday across its global operations aimed at cutting costs that will result in a charge of up to $800 million and a headcount reduction of 85 full-time positions.

Canopy said it will exit Africa, cease cultivation in Colombia, shut down its Saskatchewan production facility, and halt hemp cultivation in New York due to an oversupply of the product from last year's growing season. 

"When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn," said David Klein, Canopy’s chief executive officer, in a statement. 

Pages

Subscribe to RSS - Saskatchewan